These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 35303786)
1. Lipoproteins in the Central Nervous System: From Biology to Pathobiology. Raulin AC; Martens YA; Bu G Annu Rev Biochem; 2022 Jun; 91():731-759. PubMed ID: 35303786 [TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. DeMattos RB; Brendza RP; Heuser JE; Kierson M; Cirrito JR; Fryer J; Sullivan PM; Fagan AM; Han X; Holtzman DM Neurochem Int; 2001; 39(5-6):415-25. PubMed ID: 11578777 [TBL] [Abstract][Full Text] [Related]
3. Brain lipoprotein metabolism and its relation to neurodegenerative disease. Danik M; Champagne D; Petit-Turcotte C; Beffert U; Poirier J Crit Rev Neurobiol; 1999; 13(4):357-407. PubMed ID: 11028681 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Marais AD Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326 [TBL] [Abstract][Full Text] [Related]
11. Lipid metabolism and glial lipoproteins in the central nervous system. Hayashi H Biol Pharm Bull; 2011; 34(4):453-61. PubMed ID: 21467629 [TBL] [Abstract][Full Text] [Related]
12. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Mahley RW Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1305-15. PubMed ID: 27174096 [TBL] [Abstract][Full Text] [Related]
13. Lipoproteins in the central nervous system. Ladu MJ; Reardon C; Van Eldik L; Fagan AM; Bu G; Holtzman D; Getz GS Ann N Y Acad Sci; 2000 Apr; 903():167-75. PubMed ID: 10818504 [TBL] [Abstract][Full Text] [Related]
14. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. Raulin AC; Doss SV; Trottier ZA; Ikezu TC; Bu G; Liu CC Mol Neurodegener; 2022 Nov; 17(1):72. PubMed ID: 36348357 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease. Poirier J Mol Diagn; 1999 Dec; 4(4):335-41. PubMed ID: 10671644 [TBL] [Abstract][Full Text] [Related]
16. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update. Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307 [TBL] [Abstract][Full Text] [Related]
17. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Beffert U; Danik M; Krzywkowski P; Ramassamy C; Berrada F; Poirier J Brain Res Brain Res Rev; 1998 Jul; 27(2):119-42. PubMed ID: 9622609 [TBL] [Abstract][Full Text] [Related]
18. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches. Iurescia S; Fioretti D; Mangialasche F; Rinaldi M J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014 [TBL] [Abstract][Full Text] [Related]
19. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives. Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration. Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]